Martine Rothblatt Executes $5.25 Million Stock Sale Under 10b5-1 Plan
Martine A. Rothblatt, Chairperson and Chief Executive Officer of United Therapeutics Corp (NASDAQ:UTHR), executed a significant stock sale on July 8, 2026, totaling approximately $5,255,111. The transaction, conducted under a pre-arranged 10b5-1 trading plan, involved the sale of 9,500 shares at prices ranging from $548.62 to $560.79 per share. Thi…